VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | Daratumumab for patients with monoclonal gammopathy of renal significance

Efstathios Kastritis, MD, of University of Athens School of Medicine, Athens, Greece, outlines the use of daratumumab-based therapy for patients with monoclonal gammopathy of renal significance. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter